4
Changes in Ownership
Protagenic Therapeutics, Inc.new Filed Acc 0001493152-22-014338
Chief Financial Officer bought 31,000 shares at an average $0.71 ($22,090)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Arrow Alexander K. Chief Financial Officer | 2022-05-17 | Purchase | +23,000 | $0.71 | $16,330 | 143,260 | D |
| Arrow Alexander K. Chief Financial Officer | 2022-05-18 | Purchase | +8,000 | $0.72 | $5,760 | 151,260 | D |
| Open-market purchases · 31,000 sh · avg $0.71 · $22,090 | |||||||
Loading xslF345X03/ownership.xml…